WHO ICTRP trial
Pilot study (Phase II) of Pomalidomide, oral Desamethasone and very low-dose…
EUCTR2015-004530-94-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-004530-94-ES |
|---|---|
| Public title | Pilot study (Phase II) of Pomalidomide, oral Desamethasone and very low-dose Cyclophosphamide in patients with refractory Multiple Myeloma who have received Lenalidomide and Bortezomib. |
| Scientific title | Pilot study (Phase II) of Pomalidomide, oral Desamethasone and very low-dose Cyclophosphamide in patients with refractory Multiple Myeloma who have received Lenalidomide and Bortezomib. - FCO-PDC-2015-01 |
| Primary sponsor | Fundación para la investigación biomédica de Córdoba |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | Refractory multiple myeloma.;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Imnovid Pharmaceutical Form: Tablet INN or Proposed INN: POMALIDOMIDE CAS Number: 19171-19-8 Other descriptive name: POMALIDOMIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 4… |
| Registration date | Feb 17, 2016 |
| Target size | 20 |
| Secondary IDs | FCO-PDC-2015-01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: